OncoMed Pharmaceuticals Inc Stock-Based Compensation
OncoMed Pharmaceuticals Inc reported Stock-Based Compensation of $2.20 million for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2014-08-07
- OncoMed Pharmaceuticals Inc share-based payment arrangement, noncash expense for the quarter ending 2014-06-30 was $1.51M, a 468.68% increase year-over-year.
- OncoMed Pharmaceuticals Inc share-based payment arrangement, noncash expense for the quarter ending 2014-03-31 was $690.00K, a 206.67% increase year-over-year.
- OncoMed Pharmaceuticals Inc share-based payment arrangement, noncash expense for the quarter ending 2013-12-31 was $754.00K, a 257.35% increase year-over-year.
- OncoMed Pharmaceuticals Inc share-based payment arrangement, noncash expense for the quarter ending 2013-09-30 was $492.00K, a 135.41% increase year-over-year.
- OncoMed Pharmaceuticals Inc share-based payment arrangement, noncash expense for fiscal 2013 was $1.74M, a 107.66% increase from fiscal 2012.
- OncoMed Pharmaceuticals Inc share-based payment arrangement, noncash expense for fiscal 2012 was $836.00K, a 1.18% decline from fiscal 2011.
- OncoMed Pharmaceuticals Inc share-based payment arrangement, noncash expense for fiscal 2011 was $846.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2014-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.20M 10-Q · filed 2014-08-07 | $2.95M derived: sum of 3 quarters · filed 2014-08-07 | $3.44M derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-31 | $690.00K 10-Q · filed 2014-05-08 | $1.44M derived: sum of 2 quarters · filed 2014-05-08 | $1.94M derived: sum of 3 quarters · filed 2014-05-08 | $2.20M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-12-31 | $754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-18 | $1.25M derived: sum of 2 quarters · filed 2014-03-18 | $1.51M derived: sum of 3 quarters · filed 2014-03-18 | $1.74M 10-K · filed 2014-03-18 |
| 2013-09-30 | $492.00K 10-Q · filed 2013-11-13 | $757.00K derived: sum of 2 quarters · filed 2013-11-13 | $982.00K 10-Q · filed 2013-11-13 | $1.19M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-06-30 | $265.00K 10-Q · filed 2013-09-03 | $490.00K 10-Q · filed 2014-08-07 | $701.00K derived: sum of 3 quarters · filed 2014-05-08 | $910.00K derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-03-31 | $225.00K 10-Q · filed 2014-05-08 | $436.00K derived: sum of 2 quarters · filed 2014-05-08 | $645.00K derived: sum of 3 quarters · filed 2014-05-08 | $858.00K derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-18 | $420.00K derived: sum of 2 quarters · filed 2014-03-18 | $633.00K derived: sum of 3 quarters · filed 2014-03-18 | $836.00K 10-K · filed 2014-03-18 |
| 2012-09-30 | $209.00K 10-Q · filed 2013-11-13 | $422.00K derived: sum of 2 quarters · filed 2013-11-13 | $625.00K 10-Q · filed 2013-11-13 | |
| 2012-06-30 | $213.00K 10-Q · filed 2013-09-03 | $416.00K 10-Q · filed 2013-09-03 | ||
| 2011-12-31 | $846.00K 10-K · filed 2014-03-18 |